Philips Healthcare showcased at RSNA 2008 a hybrid SPECT/CT that incorporates a flat-panel x-ray system in place of a standard multislice CT. The FDA-cleared scanner, BrightView XCT, which debuted at the Society of Nuclear Medicine meeting in New Orleans, is built around the BrightView SPECT that Philips released commercially last year.
Philips Healthcare showcased at RSNA 2008 a hybrid SPECT/CT that incorporates a flat-panel x-ray system in place of a standard multislice CT. The FDA-cleared scanner, BrightView XCT, which debuted at the Society of Nuclear Medicine meeting in New Orleans, is built around the BrightView SPECT that Philips released commercially last year.
The novel combination is attuned specifically to the needs of specialists in nuclear medicine. The flat panel provides localization and attenuation correction at a lower cost than CT and with less technological complexity, so the system doesn't require special training for technologists, according to the company.
A side benefit is a two-thirds reduction in patient x-ray dose compared with MSCT. The XCT design is compact enough to allow siting in the same 12 x 15-foot room as the SPECT camera alone.
The system is scheduled to begin shipping next year at a price point somewhere between the company's $700,000 six-slice Precedence SPECT/CT and the $350,000 BrightView SPECT gamma camera. Beta testing is expected to begin in Q1 2009.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.